Do not Miss Rare and Treatable Cause of Early-Onset Hemolytic Uremic Syndrome: Cobalamin C Deficiency.


Journal

Nephron
ISSN: 2235-3186
Titre abrégé: Nephron
Pays: Switzerland
ID NLM: 0331777

Informations de publication

Date de publication:
2019
Historique:
received: 10 09 2018
accepted: 10 02 2019
pubmed: 29 5 2019
medline: 1 7 2020
entrez: 29 5 2019
Statut: ppublish

Résumé

The most common disorder of vitamin B12 metabolism is methylmalonic aciduria and homocystinuria type cobalamin C (cblC), which accounts for most of the cases is referred to as cblC deficiency. Cobalamin deficiency is one of the causes of early-onset hemolytic uremic syndrome (HUS). Here, we present the cases of 2 infants with cobalamin deficiency who presented with early-onset HUS. The first patient was a 5-month-old female who was admitted to the hospital with seizure, pallor, and yellow-colored diarrheal stools. Initial laboratory examination showed direct Coombs test-negative hemolytic anemia. Later, she developed acute kidney injury and thrombocytopenia. Bone marrow aspiration showed megaloblastic features, and urinary examination showed elevated levels of methylmalonic acid (MMA), -methyl citrate, and 3-hydroxypropionic acid. Methionine-restricted diet, parenteral hydroxocobalamine, folinic acid, carnitine, and betaine were initiated. Hemolytic activity was -controlled with this treatment. Genetic screening showed homozygous mutation on the MMACHCgene (p.R161*[c.481C>T]). The second patient was a 3-month-old male infant who was admitted to the hospital with malaise and diarrhea. Laboratory examination showed direct Coombs test-negative hemolytic anemia with leukopenia. Later he developed acute kidney injury and thrombocytopenia. Bone marrow aspiration revealed megaloblastic changes. Urine organic acid test showed increased levels of MMA. Parenteral hydroxocobalamine, folinic acid, carnitine, and betaine were initiated. He died due to respiratory failure and cardiac arrest. Direct sequencing of MMACHC identified homozygous mutation, c.271dup A. CblC deficiency is an important cause of early-onset HUS and prompt diagnosis will provide specific treatment modalities.

Identifiants

pubmed: 31137025
pii: 000497822
doi: 10.1159/000497822
doi:

Substances chimiques

MMACHC protein, human EC 1.-
Oxidoreductases EC 1.-

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

258-263

Informations de copyright

© 2019 S. Karger AG, Basel.

Auteurs

Rezan Topaloglu (R)

Division of Pediatric Nephrology, Department of Pediatrics, Hacettepe University, Ankara, Turkey, rezantopaloglu@hacettepe.edu.tr.

Mihriban İnözü (M)

Division of Pediatric Nephrology, Department of Pediatrics, Hacettepe University, Ankara, Turkey.

Bora Gülhan (B)

Division of Pediatric Nephrology, Department of Pediatrics, Hacettepe University, Ankara, Turkey.

Berrak Gürbüz (B)

Division of Pediatric Metabolic Diseases, Department of Pediatrics, Hacettepe University, Ankara, Turkey.

Beril Talim (B)

Division of Pathology, Department of Pediatrics, Hacettepe University, Ankara, Turkey.

Turgay Coşkun (T)

Division of Pediatric Metabolic Diseases, Department of Pediatrics, Hacettepe University, Ankara, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH